You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for New Drug Application (NDA): 209089


✉ Email this page to a colleague

« Back to Dashboard


NDA 209089 describes XYZAL ALLERGY 24HR, which is a drug marketed by Chattem Sanofi and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the XYZAL ALLERGY 24HR profile page.

The generic ingredient in XYZAL ALLERGY 24HR is levocetirizine dihydrochloride. There are thirteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the levocetirizine dihydrochloride profile page.
Summary for 209089
Tradename:XYZAL ALLERGY 24HR
Applicant:Chattem Sanofi
Ingredient:levocetirizine dihydrochloride
Patents:0
Pharmacology for NDA: 209089
Suppliers and Packaging for NDA: 209089
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XYZAL ALLERGY 24HR levocetirizine dihydrochloride TABLET;ORAL 209089 NDA Chattem, Inc. 41167-3510 41167-3510-0 1 BLISTER PACK in 1 CARTON (41167-3510-0) / 10 TABLET in 1 BLISTER PACK
XYZAL ALLERGY 24HR levocetirizine dihydrochloride TABLET;ORAL 209089 NDA Chattem, Inc. 41167-3510 41167-3510-1 1 BOTTLE in 1 CARTON (41167-3510-1) / 35 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength5MG
Approval Date:Jan 31, 2017TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.